BioSpace News Archive

Policy

Approval of extension of exemptions from SIX disclosure and publicity obligations

Vifor Pharma AG announced that by decision dated October 19, 2022, SIX Exchange Regulation AG has approved an extension of the various exemptions from certain disclosure and publicity obligations granted by SER to Vifor Pharma AG previously.

October 20, 2022
·
8 min read
Business

Biovica Appoints Anders Morén as CFO

Biovica International Biovica, active in cancer diagnostics, announces that Anders Morén has been appointed as the company’s Chief Financial Officer.

October 20, 2022
·
2 min read
Nomination Committee Appointed for the 2023 Annual General Meeting in Spago Nanomedical

Spago Nanomedical In accordance with a resolution at Spago Nanomedical AB’s Annual General Meeting on May 18, 2022, a Nomination Committee for the 2023 Annual General Meeting has been appointed.

October 20, 2022
·
1 min read
Deals

Alfasigma Acquires the Entire Share Capital of SOFAR, an Italian Pharmaceutical Company

Alfasigma S.p.A. has completed the acquisition of SOFAR S.p.A., thus officially beginning the integrating process of the two companies.

October 20, 2022
·
3 min read
Drug Development

AlzeCure Presents New Data with its Preventive Treatment Alzstatin at the Alzheimer Conference CTAD

AlzeCure Pharma announced that an abstract with new preclinical Alzstatin data has been accepted for presentation at the annual Alzheimer conference CTAD, Clinical Trials in Alzheimer’s Disease, which this year is being held in San Francisco on November 29 - December 2.

October 20, 2022
·
5 min read
Business

Hansa Biopharma Interim report January-September 2022

Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, announced its business update and interim report for January to September 2022.

October 20, 2022
·
8 min read
Business

Nomination Committee appointed for the 2023 Annual General Meeting of Immunovia AB (Publ)

According to the instructions for the Nomination Committee of Immunovia AB that were adopted at the Annual General Meeting on April 7, 2022, the Nomination Committee shall consist of four members.

October 20, 2022
·
3 min read
Policy

BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing

BGI Australia’s lab has achieved accreditation from the National Association of Testing Authorities to perform clinical Whole Exome Sequencing in Australia, paving the way for the global life sciences company to provide clinical sequencing services for identifying possible disease-causing genetic changes.

October 20, 2022
·
3 min read
Drug Development

Harbour BioMed Announces Dosing of First Patient in Phase I Trial of B7H4x4-1BB Bispecific Antibody in the United States

Harbour BioMed announced that, it has successfully completed the dosing of first patient in the global phase I trial of B7H4x4-1BB bispecific antibody HBM7008 in the United States.

October 20, 2022
·
3 min read
Business

University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs

University of Tübingen, a leading member of Cyber Valley, Europe’s largest Artificial Intelligence research consortium and Boehringer Ingelheim launch an AI and data science fellowship program for top talents from around the world.

October 20, 2022
·
5 min read